Workflow
Artiva Biotherapeutics to Participate in the Jefferies Global Healthcare Conference
Globenewswire· 2025-05-28 20:05
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025, at 9:20 a.m. EDT. Members of the Artiva management team will also be available to participate in investo ...
Parsons to Present at the William Blair 45th Annual Growth Stock Conference
Globenewswire· 2025-05-28 20:05
CHANTILLY, Va., May 28, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) chair, president, and chief executive officer, Carey Smith, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, at approximately 11:20 a.m. Central Time. This presentation will be available live via webcast on the investor relations section of Parsons’ website (https://investors.parsons.com/). A replay of the webcast also will be available on the website for 30 days. About Parsons Cor ...
Sanuwave Health Appoints Greg Bazar to Board of Directors
Globenewswire· 2025-05-28 20:05
Bazar brings decades of experience in engineering, computer science and cyber security, AI, and business intelligence over a career of building successful companiesEDEN PRAIRIE, Minn., May 28, 2025 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (Nasdaq:SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to announce the addition of Greg Bazar to its Board of Directors. Bazar brings decades of leadership experience in engineering, technology, and ...
Silvaco To Present at the Rosenblatt 5th Annual Technology Summit
Globenewswire· 2025-05-28 20:05
SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today announced that Silvaco’s Chief Executive Officer, Dr. Babak Taheri, Interim Chief Financial Officer, Keith Tainsky, and Chief Revenue Officer, Ian Chen, will participate in a fireside chat at the Rosenblatt 5th Annual Technology Summit on Wednesday, June 11, ...
ORIC® Pharmaceuticals Announces $125 Million Private Placement Financing
Globenewswire· 2025-05-28 20:05
Financing led by SR One and includes participation from new and existing investors, including Point72, Viking Global Investors, Venrock Healthcare Capital Partners, New Enterprise Associates (NEA), Nextech, Vivo Capital, and NEXTBio Capital Pro forma cash and investments expected to fund current operating plan into the second half of 2027 and through anticipated primary endpoint readout from first ORIC-944 Phase 3 registrational trial in prostate cancer SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 28, 202 ...
Pulmonx to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
Globenewswire· 2025-05-28 20:05
REDWOOD CITY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced the company will be presenting at the Goldman Sachs 46th Annual Global Health Care Conference in Miami on Wednesday, June 11, 2025, at 7:00 AM PT / 10:00 AM ET. A live and archived webcast of the presentation will be available on “Investors” section of the Pulmonx website at https://investors.pulmonx.com/. A ...
Amaero Provides Update to Financial Guidance, Largely Reaffirming Expectations
Globenewswire· 2025-05-28 20:05
~ Revenue to Accelerate in Current Quarter with a Continuation of Growth into FY 2026 ~ ~ Company Expects to be EBITDA Positive in FY 2027 ~ MCDONALD, Tenn., May 28, 2025 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTCQB: AMROF) (“Amaero” or the “Company”), a leading U.S. domestic producer of high-value C103, refractory alloy, and titanium powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, provided an update to its financial outlook, largely ...
Sana Biotechnology to Present at June 2025 Investor Conferences
Globenewswire· 2025-05-28 20:05
SEATTLE, May 28, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at two investor conferences in June. The presentations will feature a business overview and update. Sana will present at the Jefferies Global Healthcare Conference at 2:35 p.m. ET on Wednesday, June 4, 2025.Sana will present at the Goldman Sachs 46th Annual Global Healthcare Conference at 8: ...
LPL Financial to Present at the William Blair Growth Stock Conference
Globenewswire· 2025-05-28 20:05
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- LPL Financial LLC (Nasdaq:LPLA) today announced that Matt Audette, President and Chief Financial Officer, will present at the William Blair Growth Stock Conference on June 4. The presentation takes place at 11 a.m. ET. A live audio webcast of the presentation will be accessible at investor.lpl.com, with a replay available on the website after the presentation. Contacts Investor Relationsinvestor.relations@lplfinancial.com Media Relationsmedia.relations@lplfinancia ...
Supernus Announces Paragraph IV ANDA Filings for Qelbree®
Globenewswire· 2025-05-28 20:05
ROCKVILLE, Md., May 28, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the Company received Paragraph IV Notice Letters from third parties notifying Supernus that the third parties submitted Abbreviated New Drug Applications (ANDAs) for viloxazine extended-release capsules, eq. 100, 150, and 200 mg base. Supernus is currently ...